Figure 2
From: Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes
No significant difference in IL10R1 expression on monocytes in T2D.
IL10R1 was measured on CD14+/CD16− and CD16+ monocytes by flow cytometry in the T2D and age and BMI-matched non-T2D control participants. Unpaired t-tests indicated that IL10R1 expression was not significantly different on either monocyte subset although IL10R1 tended to be lower on CD14+/CD16− classical monocytes in T2D (P = 0.057). Values are mean ± SEM.
